Exact Sciences Corp
EXAS53.570USD
-0.110-0.20%
Handelsschluss 09/26, 16:00（ET）Kurse um 15 Minuten verzögert
10.14BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Unternehmen
Unternehmensinformationen
BörsenkürzelEXAS
Name des UnternehmensExact Sciences Corp
IPO-datumJan 30, 2001
CEOMr. Kevin T. Conroy
Anzahl der mitarbeiter6900
WertpapierartOrdinary Share
GeschäftsjahresendeJan 30
Addresse5505 Endeavor Lane
StadtMADISON
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl53719
Telefon16082845700
Websitehttps://www.exactsciences.com/
BörsenkürzelEXAS
IPO-datumJan 30, 2001
CEOMr. Kevin T. Conroy
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin T. Conroy
Mr. Kevin T. Conroy
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.14M
-20.54%
Ms. Katherine S. (Kay) Zanotti
Ms. Katherine S. (Kay) Zanotti
Independent Director
Independent Director
72.76K
+3.10%
Mr. Daniel J. (Dan) Levangie
Mr. Daniel J. (Dan) Levangie
Independent Director
Independent Director
34.31K
+18.67%
Ms. Shacey Petrovic
Ms. Shacey Petrovic
Independent Director
Independent Director
28.90K
+22.97%
Mr. Brian Baranick
Mr. Brian Baranick
Executive Vice President, General Manager - Precision Oncology
Executive Vice President, General Manager - Precision Oncology
25.90K
+11.32%
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Independent Director
Independent Director
17.17K
+80.75%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
16.38K
+156.47%
Mr. Aaron Bloomer
Mr. Aaron Bloomer
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
13.84K
--
Mr. Michael J. (Mike) Barber, M.D.
Mr. Michael J. (Mike) Barber, M.D.
Independent Director
Independent Director
13.14K
+121.18%
Mr. James E. Doyle
Mr. James E. Doyle
Lead Independent Director
Lead Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin T. Conroy
Mr. Kevin T. Conroy
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.14M
-20.54%
Ms. Katherine S. (Kay) Zanotti
Ms. Katherine S. (Kay) Zanotti
Independent Director
Independent Director
72.76K
+3.10%
Mr. Daniel J. (Dan) Levangie
Mr. Daniel J. (Dan) Levangie
Independent Director
Independent Director
34.31K
+18.67%
Ms. Shacey Petrovic
Ms. Shacey Petrovic
Independent Director
Independent Director
28.90K
+22.97%
Mr. Brian Baranick
Mr. Brian Baranick
Executive Vice President, General Manager - Precision Oncology
Executive Vice President, General Manager - Precision Oncology
25.90K
+11.32%
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Independent Director
Independent Director
17.17K
+80.75%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Commercial
332.50M
47.04%
Medicare Parts B & C
247.89M
35.07%
Other
74.81M
10.58%
International
51.59M
7.30%
Nach RegionUSD
Name
Umsatz
Anteil
United States (Country)
655.20M
92.70%
Outside of united states
51.59M
7.30%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Commercial
332.50M
47.04%
Medicare Parts B & C
247.89M
35.07%
Other
74.81M
10.58%
International
51.59M
7.30%
Aktionärsstatistik
Aktualisiert: Sat, Aug 16
Aktualisiert: Sat, Aug 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
12.30%
Capital World Investors
9.61%
The Vanguard Group, Inc.
9.44%
Wellington Management Company, LLP
6.34%
BlackRock Institutional Trust Company, N.A.
3.72%
Andere
58.59%
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
12.30%
Capital World Investors
9.61%
The Vanguard Group, Inc.
9.44%
Wellington Management Company, LLP
6.34%
BlackRock Institutional Trust Company, N.A.
3.72%
Andere
58.59%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
56.40%
Investment Advisor/Hedge Fund
27.98%
Hedge Fund
6.47%
Research Firm
2.05%
Pension Fund
0.94%
Individual Investor
0.92%
Bank and Trust
0.69%
Sovereign Wealth Fund
0.48%
Private Equity
0.32%
Andere
3.76%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
1403
202.48M
106.98%
+2.53M
2025Q1
1424
199.78M
106.03%
-445.52K
2024Q4
1411
200.72M
108.09%
-225.66K
2024Q3
1375
190.82M
103.28%
-5.17M
2024Q2
1358
185.25M
100.40%
+6.59M
2024Q1
1347
168.41M
92.78%
-6.10M
2023Q4
1356
165.31M
91.41%
-11.01M
2023Q3
1337
167.70M
92.83%
-6.22M
2023Q2
1354
166.38M
92.24%
-10.65M
2023Q1
1343
167.01M
92.90%
-8.56M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fidelity Management & Research Company LLC
24.14M
12.8%
+5.29M
+28.03%
Mar 31, 2025
Capital World Investors
17.84M
9.45%
+297.66K
+1.70%
Mar 31, 2025
The Vanguard Group, Inc.
17.56M
9.31%
+616.59K
+3.64%
Mar 31, 2025
Wellington Management Company, LLP
12.50M
6.63%
+442.78K
+3.67%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
7.68M
4.07%
+12.62K
+0.16%
Mar 31, 2025
State Street Global Advisors (US)
6.61M
3.51%
+381.12K
+6.11%
Mar 31, 2025
Fidelity Institutional Asset Management
3.59M
1.9%
+1.68M
+88.60%
Mar 31, 2025
T. Rowe Price Associates, Inc.
6.25M
3.32%
+631.23K
+11.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
3.27M
1.73%
+143.64K
+4.60%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Name
Anteil
Calvert US Select Equity ETF
0%
iShares MSCI USA Equal Weighted ETF
0%
Fidelity Momentum Factor ETF
0%
Zacks Small/Mid Cap ETF
0%
JPMorgan US Momentum Factor ETF
0%
iShares ESG Aware MSCI USA ETF
0%
Amplify AI Powered Equity ETF
0%
Goldman Sachs ActiveBeta US Large Cap Equity ETF
0%
Inspire Global Hope ETF
0%
Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF
0%
Mehr Anzeigen
Calvert US Select Equity ETF
Anteil0%
iShares MSCI USA Equal Weighted ETF
Anteil0%
Fidelity Momentum Factor ETF
Anteil0%
Zacks Small/Mid Cap ETF
Anteil0%
JPMorgan US Momentum Factor ETF
Anteil0%
iShares ESG Aware MSCI USA ETF
Anteil0%
Amplify AI Powered Equity ETF
Anteil0%
Goldman Sachs ActiveBeta US Large Cap Equity ETF
Anteil0%
Inspire Global Hope ETF
Anteil0%
Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
